07-13-2017 04:52 PM CET - Business, Economy, Finances, Banking & Insurance
Print

Lawsuit against Allergan plc (NYSE:AGN) for investors who sold call options purchased put options and/or sold equity forward contracts of Allergan plc

Press release from: Shareholders Foundation
A lawsuit was filed on behalf of investors in Allergan plc (NYSE:AGN) shares over alleged securities laws violations.
A lawsuit was filed on behalf of investors in Allergan plc (NYSE:AGN) shares over alleged securities laws violations.
The Shareholders Foundation announces that an investor in Allergan plc (NYSE:AGN) filed a lawsuit over alleged Securities Laws violations by Allergan plc.

Investors who sold the call options, purchased the put options and/or sold equity forward contracts of Allergan plc (NYSE:AGN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint the plaintiff alleges on behalf of investors who sold the call options, purchased the put options and/or sold equity forward contracts of Allergan plc (NYSE:AGN) common shares between February 25, 2014 through April 21, 2014, that the defendants violated Federal Securities Laws.

More specifically, the plaintiff claims that between February 25, 2014 through April 21, 2014, certain Defendants traded on material non-public information regarding the proposed acquisition, and as a result, investors who sold the call options, purchased the put options and/or sold equity forward contracts of Allergan, Inc between February 25, 2014 through April 21, 2014 did so at prices that did not reflect the material nonpublic information known to Defendants. In this action, Plaintiff seeks an award of damages, and prejudgment interest, to Plaintiff and investors who sold the call options, purchased the put options and/or sold equity forward contracts of Allergan plc (NYSE:AGN) common shares between February 25, 2014 through April 21, 2014.

Those who sold the call options, purchased the put options and/or sold equity forward contracts of Allergan plc (NYSE:AGN) have certain options and should contact the Shareholders Foundation.

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

This release was published on openPR.
News-ID: 619936 • Views: 198
More releases More releases
Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.

You can edit or delete your press release here: